Literature DB >> 30588754

Schuurs-Hoeijmakers syndrome in two patients from Japan.

Yusuke Hoshino1, Takashi Enokizono2, Kazuo Imagawa2, Ryuta Tanaka2, Hisato Suzuki2, Hiroko Fukushima2, Junichi Arai1, Ryo Sumazaki2, Tomoko Uehara3, Toshiki Takenouchi3, Kenjiro Kosaki3.   

Abstract

Schuurs-Hoeijmakers syndrome is a rare disease characterized by intellectual disability and dysmorphic facial features among various physical abnormalities due to PACS1 mutation. To date, 28 patients with a recurrent de novo PACS1 mutation (c.607C > T) have been reported, primarily in Western populations. Here, we describe two Japanese patients with Schuurs-Hoeijmakers syndrome with a recurrent PACS1 mutation. In addition to the typical clinical symptoms, each patient presented novel clinical phenotypes. One patient presented with involuntary movements and was treated with trihexyphenidyl hydrochloride. We hypothesized that the PACS1 mutation leads to an inherent dopaminergic insufficiency that underlies the developing symptoms along with the neurodevelopmental processes. The second patient was diagnosed with lipomyelomeningocele during an examination for severe constipation at the age of 2 years and 8 months. The diagnosis of lipomyelomeningocele in this patient was delayed due to the lack of cutaneous lesions. As the majority of patients with PACS1 mutation present constipation, underdiagnosis of lipomyelomeningocele is a possibility. As the phenotypic expansion of the patients with Schuurs-Hoeijmakers syndrome was not fully recognized, additional studies are needed to clarify the clinical spectrum.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  PACS1; Schuurs-Hoeijmakers syndrome; c.607C > T; lipomyelomeningocele

Mesh:

Substances:

Year:  2018        PMID: 30588754     DOI: 10.1002/ajmg.a.9

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

Review 1.  Molecular Basis of the Schuurs-Hoeijmakers Syndrome: What We Know about the Gene and the PACS-1 Protein and Novel Therapeutic Approaches.

Authors:  María Arnedo; Ángela Ascaso; Ana Latorre-Pellicer; Cristina Lucia-Campos; Marta Gil-Salvador; Ariadna Ayerza-Casas; María Jesús Pablo; Paulino Gómez-Puertas; Feliciano J Ramos; Gloria Bueno-Lozano; Juan Pié; Beatriz Puisac
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

2.  Schuurs-Hoeijmakers Syndrome (PACS1 Neurodevelopmental Disorder): Seven Novel Patients and a Review.

Authors:  Jair Tenorio-Castaño; Beatriz Morte; Julián Nevado; Víctor Martinez-Glez; Fernando Santos-Simarro; Sixto García-Miñaúr; María Palomares-Bralo; Marta Pacio-Míguez; Beatriz Gómez; Pedro Arias; Alba Alcochea; Juan Carrión; Patricia Arias; Berta Almoguera; Fermina López-Grondona; Isabel Lorda-Sanchez; Enrique Galán-Gómez; Irene Valenzuela; María Pilar Méndez Perez; Ivón Cuscó; Francisco Barros; Juan Pié; Sergio Ramos; Feliciano J Ramos; Alma Kuechler; Eduardo Tizzano; Carmen Ayuso; Frank J Kaiser; Luis A Pérez-Jurado; Ángel Carracedo; Pablo Lapunzina
Journal:  Genes (Basel)       Date:  2021-05-13       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.